← FDA DRUG APPROVALS

FDA ANDA · ANDA071740

ACETYLCYSTEINE

Sponsor: QUAD PHARMS

APPLICATION
ANDA071740
TYPE
ANDA
ROUTE
Inhalation, Oral
DOSAGE FORM
Solution
MARKETING STATUS
Discontinued

Products

ACETYLCYSTEINEDiscontinued
ACETYLCYSTEINE 10% · Solution · Inhalation, Oral
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →